Artivion (AORT): Perceptive reports 2,020,000 shares, 4.3% stake
Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. filed an amended Schedule 13G reporting beneficial ownership of 2,020,000 shares of Artivion, Inc. (AORT) common stock, representing 4.3% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. filed an amended Schedule 13G reporting beneficial ownership of 2,020,000 shares of Artivion, Inc. (AORT) common stock, representing 4.3% of the class. The percentage is based on 47,374,939 shares outstanding as of October 31, 2025, as disclosed by the company.
The filers report shared voting power and shared dispositive power over 2,020,000 shares, with no sole voting or dispositive power. They certify the holdings were not acquired to change or influence control of Artivion.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Perceptive disclose about AORT in this Schedule 13G/A?
Who are the reporting persons in the AORT 13G/A filing?
Does the filing state an intent to influence control of Artivion (AORT)?
What is the type/classification of the reporting persons?
What is the date of the event requiring this AORT filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.